| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.16 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.5 |